Medical Therapy and Revascularization for Asymptomatic Carotid Stenosis | Results of the CREST-2 Trial

Tuesday, March 10, 2026

8:15 AM - 8:23 AM EST

Location: International Ballroom Center

Speaker(s)

Gary Roubin, MD PhD

Chair
CREST2 Trial Interventional Management Committee
Jackson, Wyoming, United States

Disclosure(s): Cardiomech Inc: Stock-privately held company (Ongoing); Contego Medical Inc: Stock Options [in privately held companies] (Ongoing); Excision Medical Inc: Stock-privately held company (Ongoing); Inspire MD Inc: Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Disclosure(s):

Gary Roubin, MD PhD: Cardiomech Inc: Stock-privately held company (Ongoing); Contego Medical Inc: Stock Options [in privately held companies] (Ongoing); Excision Medical Inc: Stock-privately held company (Ongoing); Inspire MD Inc: Stock-publicly held company (excluding mutual/index funds) (Ongoing)